Diligence memo · auto-generated · as of July 3, 2026
Los Angeles Biosciences, Inc.
Los Angeles Biosciences, Inc. looks fair against its niche peers and is active on financing cadence.
Businessfiled
Los Angeles Biosciences, Inc. operates in Biotech / Pharma, based in PLAYA DEL REY.
No verified homepage on file yet — operating evidence is limited to the public record.
Capital & rounds (filed)filed
Los Angeles Biosciences, Inc. has raised $4.9M in disclosed capital across 1 recorded round, aggregated from public filings. Its latest round is modeled as Series A (a $4.0M–$15M round).
Largest single filing: $4.9M on 2025-06-09.
Most recent recorded round closed around 2025-06-09.
Valuation (modeled)modeled
Provath models Los Angeles Biosciences, Inc. at approximately $16M (range $5.4M–$29M). This is an algorithmic estimate from round sizes and same-niche peers — not a quoted or reported figure.
Read: Fair. Modeled value is 0.96× the median modeled value of Series A Biotech / Pharma companies in 2025–2027 (16 peers) — value vs value, same stage and era. Within the normal band (96% of peer median) for its niche.
Financing rhythm & timingmixed
Last raise 13 mo ago; this sector typically re-raises about every 15 months.
Raising on or ahead of the sector's normal rhythm.
Comparablesmixed
Capital scale ranks ahead of 49% of Biotech / Pharma peers (227 compared).
Modeled value ranks above 39% of those peers.
Closest niche peers: Evio Pharmacy Solutions, LLC, Ruby Bio, Inc., Intelligent Bio Solutions Inc., Barnwell Bio, Inc., Arkea Bio Corp..
Peoplefiled
3 named people on file across officers, directors and signatories.
Risks & flagsmixed
No clearly named CEO/founder/principal in the surfaced records — key-person evidence is thin.